blinatumomab - CISMeF

Preferred Label : blinatumomab;

MeSH note : a single-chain bispecific recombinant antibody from Micromet's BiTE (bispecific T-cell engager) product platform that binds both the CD19 antigen and the T-cell receptor (CD3), for the potential treatment of B-cell lymphoma;

CISMeF synonym : MT-103 antibody;

MeSH hyponym : antibody MT-103;

Is substance : O;

UNII : 4FR53SIF3A;

Details

Origin ID

C510808;

UMLS CUI

C3853839;

ATC code(s)
- blinatumomab [ATC Code]
CISMeF manual mappings
- Blinatumomab (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Blinatumomab [NCIt concept]
- Blinatumomab [Substance BNPC]
MeSH term(s) associated for indexing
- antibodies, bispecific [MeSH Descriptor]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
Record concept(s)
- Blincyto [MeSH concept]
- MEDI-538 [MeSH concept]
- MT-103 antibody [MeSH concept]
- blinatumomab [MeSH concept]
See also inter- (CISMeF)
- Product containing blinatumomab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Blinatumomab [NCIt concept]
- Blinatumomab [Substance BNPC]
- Blinatumomab (substance) [SNOMED CT concept]
- Product containing blinatumomab (medicinal product) [SNOMED CT concept]
- blinatumomab [ATC Code]
Validated automatic mappings to BTNT
- blinatumomab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients